The Veteran's initial compensable rating for a basal cell carcinoma scar on the left lower cheek was denied. The Board also remanded the issue of service connection for plantar fasciitis due to insufficient evidence.
The deciding factor: Insufficient evidence regarding the etiology and progression of the Veteran's plantar fasciitis, particularly from his first period of active duty service.
- Claimed conditions
- Basal cell carcinoma scar, Plantar fasciitis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- June 19, 2019
- Citation
- 19147880
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Board denied an initial rating greater than 30 percent for plantar fasciitis as the evidence did not support a higher rating.
- Dismissed
The appeal was denied due to the untimely filing of the Board Appeal request.
- Dismissed
The appeal was dismissed due to untimely filing of the Notice of Disagreement (NOD) for claims related to an increased rating and service connection, as well as lack of jurisdiction over a previously granted claim for sinusitis.
- Denied
The Board denied the Veteran's claim for service connection for a right foot disability, to include plantar fasciitis, as there was no evidence of an in-service injury or event related to the current condition.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.